Sort
141,003 grants matching “cytokine”
Rational targeting of Cdc42 to benefit immunotherapy
$594,402Yi Zheng · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · CA
Rational targeting of Cdc42 to benefit immunotherapy
$594,402Yi Zheng · Cincinnati Childrens Hosp Med Ctr · R01 · FY2025 · CA
Dendritic cell subsets in autoimmune diabetes
$594,400Kristin Tarbell · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2013 · DK
Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome
$594,393Gary Andrew Weisman · University Of Missouri-Columbia · R01 · FY2022 · DE
Stress, the Immune System and Basal Cell Carcinoma
$594,388Ronald Glaser · Ohio State University · R01 · FY2007 · CA
Project 3 Determinants of Vaccine Efficacy
$594,375Samuel M Behar · Univ Of Massachusetts Med Sch Worcester · P01 · FY2024 · AI
Effects of chronic inflammation on brain structure and function
$594,361Joel H Kramer · University Of California, San Francisco · R01 · FY2017 · AG
Histopathology, Neuroimaging and Mechanism of Myelin Damage in Aging Monkey Brain
$594,360Douglas L Rosene · Boston University Medical Campus · R01 · FY2013 · AG
Histopathology, Neuroimaging and Mechanism of Myelin Damage in Aging Monkey Brain
$594,360Douglas L Rosene · Boston University Medical Campus · R01 · FY2016 · AG
Histopathology, Neuroimaging and Mechanism of Myelin Damage in Aging Monkey Brain
$594,360Douglas L Rosene · Boston University Medical Campus · R01 · FY2014 · AG
Metabolic perturbations in conventional dendritic cells modulate Tfh13 induction in asthmatic sensitization
$594,338Rebecca Kelley Martin · Virginia Commonwealth University · R01 · FY2024 · HL
Natural Killer Cell Tolerance to Self
$594,316Wayne M. Yokoyama · Washington University · R01 · FY2023 · AI
VITAMIN D AND IMMUNOMODULATION IN CORONARY ARTERY DISEASE
$594,294Devendra K. Agrawal · Creighton University · R01 · FY2013 · HL
In search of an HBV cure: novel model systems and targets
$594,284Charles M. Rice · Rockefeller University · R01 · FY2023 · AI
In search of an HBV cure: novel model systems and targets
$594,284Charles M. Rice · Rockefeller University · R01 · FY2022 · AI
In search of an HBV cure: novel model systems and targets
$594,284Charles M. Rice · Rockefeller University · R01 · FY2021 · AI
In search of an HBV cure: novel model systems and targets
$594,284Charles M. Rice · Rockefeller University · R01 · FY2020 · AI
Defining genetic pathways to severe systemic autoimmunity
$594,270Edward K Wakeland · Ut Southwestern Medical Center · R01 · FY2009 · AI
Angiogenesis-targeting therapy for glioblastoma
$594,234Tracy T Batchelor · Massachusetts General Hospital · R01 · FY2013 · CA
Innate immune responses to SARS-CoV-2 infection in the olfactory epithelium
$594,228Qizhi Gong · University Of California At Davis · R01 · FY2025 · DC
Defining the T-cell Response to Human Renal Cancer
$594,220James C Yang · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA
Molecular Control of Plasmacytoid Dendritic Cell Development and Function
$594,130Boris Reizis · New York University School Of Medicine · R37 · FY2018 · AI
Molecular Control of Plasmacytoid Dendritic Cell Development and Function
$594,130Boris Reizis · New York University School Of Medicine · R37 · FY2019 · AI
Type-2 inflammation mediates olfactory loss in Chronic Rhinosinusitis: mechanisms and therapeutic opportunities
$594,099Bruce K Tan · Northwestern University At Chicago · R01 · FY2022 · DC
Type-2 inflammation mediates olfactory loss in Chronic Rhinosinusitis: mechanisms and therapeutic opportunities
$594,099Bruce K Tan · Northwestern University At Chicago · R01 · FY2021 · DC